Riken Vitamin Co., Ltd. (TYO:4526)

Riken Vitamin Revenue

In the fiscal year ending March 31, 2026, Riken Vitamin had annual revenue of 96.30B JPY with 0.75% growth. Riken Vitamin had revenue of 23.80B in the quarter ending March 31, 2026, with 4.69% growth.

• Revenue: 96.30B
• Revenue Growth: +0.75%
• P/S Ratio: 0.93
• Revenue / Employee: 51.03M
• Employees: 1,858
• Market Cap: 89.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	96.30B	718.00M	0.75%
Mar 31, 2025	95.58B	4.10B	4.48%
Mar 31, 2024	91.48B	2.73B	3.08%
Mar 31, 2023	88.75B	9.52B	12.01%
Mar 31, 2022	79.23B	1.51B	1.94%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 24, 2026

Data Sources Report a data error